Announced
Completed
Synopsis
Lesaffre, a key global player in the production of yeast and yeast extract, completed the acquisition of Altar, a French start-up specializing in Adaptive Laboratory Evolution, from Ginkgo Bioworks, a biotechnology company in Boston, Massachusetts. Financial terms were not disclosed. "At Lesaffre, we are convinced that today's RD&I are the products of tomorrow. By investing today in our innovation capabilities, we give our research and development experts the means to develop healthier, more sustainable products that best meet the needs of our customers. We are very pleased to welcome the Altar team to Lesaffre and to be able to join forces to build the solutions of tomorrow together," Christine M'Rini, Lesaffre Chief RD&I Officer.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2025 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.